Primary ovary transitional cell carcinoma after renal transplantation

Journal of the Chinese Medical Association

Volumn 74, Issue 5, 2011, Pages 230-232

  Yu, Chung Cheng ^a   Chen, Sung Lang ^a   Lian, Jong Da ^a   Koo, Chiew Loon ^a   Shih, Yang Tse ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Kidney transplantation; Ovary; Transitional cell carcinoma

Indexed keywords

ABAGOVOMAB; CARBOPLATIN; GEMCITABINE;

ABDOMINAL HYSTERECTOMY; AGED; ARTICLE; ATROPHY; BLADDER SURGERY; CADAVER; CANCER CHEMOTHERAPY; CANCER INVASION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; GYNECOLOGIC SURGERY; HUMAN; HYDRONEPHROSIS; IMMUNOHISTOCHEMISTRY; KIDNEY SURGERY; KIDNEY TRANSPLANTATION; LABORATORY TEST; LYMPH NODE DISSECTION; MICROSCOPY; OVARY CARCINOMA; OVARY TUMOR; PATHOLOGY; PELVIS; POSTOPERATIVE CARE; SALPINGOOOPHORECTOMY; TRANSITIONAL CELL CARCINOMA;

AGED; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; OVARIAN NEOPLASMS;

EID: 79955641576     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2011.03.009     Document Type: Article

References (15)

1. Sheil A.G., Disney A.P., Mathew T.H., Livingston B.E., Keogh A.M. Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation. Transplant Proc 1997, 29:825-827.
2. Penn I. Cancers in renal transplant recipients. Adv Ren Replace Ther 2000, 7:147-156.
3. Wu M.J., Lian J.D., Yang C.R., Cheng C.H., Chen C.H., Lee W.C., et al. High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan. Am J Kidney Dis 2004, 43:1091-1097.
4. Hung Y.M., Chou K.J., Hung S.Y., Chung H.M., Chang J.C. De novo malignancies after kidney transplantation. Urology 2007, 69:1041-1044.
5. Cuatrecasas M., Catasus L., Palacios J., Prat J. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas. Am J Surg Pathol 2009, 33:556-567.
6. Oh S.N., Rha S.E., Jung S.E., Lee Y.J., Choi B.G., Byun J.Y., et al. Transitional cell tumor of the ovary: computed tomographic and magnetic resonance imaging features with pathological correlation. J Comput Assist Tomogr 2009, 33:106-112.
7. Austin R.M., Norris H.J. Malignant Brenner tumor and transitional cell carcinoma of the ovary: a comparison. Int J Gynecol Pathol 1987, 6:29-39.
8. Schaafsma H.E., Ramaekers F.C. Cytokeratin subtyping in normal and neoplastic epithelium: basic principles and diagnostic applications. Pathol Annu 1994, 29:21-62.
9. Ceauşu M., Terzea D., Georgescu A., Dobrea C., Mihai M., Iosif C., et al. Transitional cell tumors of the ovary: a compact group with a heterogeneous histological and immunophenotypical pattern. Rom J Morphol Embryol 2008, 49:513-516.
10. Han A.C., Duszak R. Coexpression of cytokeratins 7 and 20 confirms urothelial carcinoma presenting as an intrarenal tumor. Cancer 1999, 86:2327-2330.
11. Campbell F., Herrington C.S. Application of cytokeratin 7 and 20 immunohistochemistry to diagnostic pathology. Curr Diagn Pathol 2001, 7:113-122.
12. Eichhorn J.H., Young R.H. Transitional cell carcinoma of the ovary: a morphologic study of 100 cases with emphasis on differential diagnosis. Am J Surg Pathol 2004, 28:453-463.
13. Ordonez N.G. Transitional cell carcinomas of the ovary and bladder are immunophenotypically different. Histopathology 2000, 36:433-438.
14. Gershenson D.M., Silva E.G., Mitchell M.F., Atkinson E.N., Wharton J.T. Transitional cell carcinoma of the ovary: a matched control study of advanced-stage patients treated with cisplatin-based chemotherapy. Am J Obstet Gynecol 1993, 168:1178-1185.
15. Kommoss F., Kommoss S., Schmidt D., Trunk M.J., Pfisterer J., du Bois A. Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxel. Gynecol Oncol 2005, 97:195-199.